Fount of Information

AcroBiosystems社 How many targets for bispecific antibody development do you know?

この製品に関するご意見・ご照会・お問合せはこちら

How_many_targets_for_bispecific_antibody_development_do_you_know_1.png

How many targets for bispecific antibody development do you know?

How_many_targets_for_bispecific_antibody_development_do_you_know_2.png

Hot Targets
CD3 proteins
How_many_targets_for_bispecific_antibody_development_do_you_know_3.png

Features:

 

> MALS verified heterodimer

> High bioactivity and batch-to-batch consistency

> Bioactivity verified by clinical bispecific antibody

> Various tags and species

 

>>> Learn more about CD3 protein
PD-1/PD-L1 Proteins
How_many_targets_for_bispecific_antibody_development_do_you_know_4.png

Features:

 

> High purity and homogeneity

> High bioactivity verified

> Various tags and species

 

>>> Learn more about immune checkpoint targets
CD47 Proteins
How_many_targets_for_bispecific_antibody_development_do_you_know_5.png

Features:

 

> High purity and homogeneity

> High bioactivity verified

> Suitable for immunization and inhibitor

 

>>> Learn more about CD47 proteins
Full length CD20 Proteins
How_many_targets_for_bispecific_antibody_development_do_you_know_6.png

Features:

 

> Authentic conformation

> Super bioactivity verified

> Exclusive Nanodisc technology

 

>>> Learn more about CD20 proteins
More bispecific antibody targets

How_many_targets_for_bispecific_antibody_development_do_you_know_7.jpg

Bioactivity analysis of bispecific antibody

According to Bispecific Antibody Development Programs Guidance for Industry (FDA, 2019), quality attributes may affect pharmacology and should be studied.

 

With a strong team of scientists, ACROBiosystems also provides high-quality integrated SPR&BLI analytical services. ACROBiosystems has served and collaborated with more than 200 customers from academia and industry. Our work supported multiple antibody drugs IND applications.

 

Fount of Information は、新商品、新規取扱メーカーなどの情報をいち早く紹介するコンテンツです。情報発信のスピードを重視しているコンテンツのため、現時点で法規制や取り扱いを確認できていない商品、定価を設定できていない商品があります。ご要望やご照会を受けた商品について、法令整備や在庫の充実を図ります。